|Umut Gurkan, PhD|
1 United States site
> 12 Years
– Male or female ≥12 years of age at the time of consent (enrollment).
– Documentation Sickle Cell Disease, including HbSS or compound heterozygus HbSC- or
HbSβ- thalassemia diagnosis as evidenced by one or more clinical features.
– Written informed consent (and assent when applicable) obtained from subject or
subject’s legal representative and ability for subject to comply with the requirements
of the study.
– Presence of a condition or abnormality that in the opinion of the Investigator would
compromise the safety of the patient or the quality of the data.